Skip to main content
. 2021 Apr 25;23(10):1612–1676. doi: 10.1093/europace/euab065

Figure 5.

Figure 5

Absorption and metabolism of the different NOACs. There are interaction possibilities at the level of absorption or first transformation, and at the level of metabolization and excretion. aAlso via CYP1A2, CYP2J2, CYP2C8, CYP2C9, and CYP2C19. NOAC, non-vitamin K antagonist oral anticoagulant.